Myovant Sciences Ltd. — Operating Income by Fiscal Year
6 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/70d5cc3c-c0f9-4e7b-822f-4a47270fafe2/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2021 | $-187.3M | 2021-04-01 – 2022-03-31 | evidence 0001679082-22-000071 |
| FY 2020 | $-260.8M | 2020-04-01 – 2021-03-31 | evidence 0001679082-21-000017 |
| FY 2019 | $-274.9M | 2019-04-01 – 2020-03-31 | evidence 0001679082-21-000017 |
| FY 2018 | $-264.8M | 2018-04-01 – 2019-03-31 | evidence 0001679082-21-000017 |
| FY 2017 | $-143.0M | 2017-04-01 – 2018-03-31 | evidence 0001679082-18-000016 |
| FY 2016 | $-83.5M | 2016-04-01 – 2017-03-31 | evidence 0001679082-17-000009 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).